Your session is about to expire
← Back to Search
Robotic Exoskeleton
Adaptive Hip Exoskeleton for Stroke Rehabilitation
N/A
Waitlist Available
Led By Aaron Young, Ph.D.
Research Sponsored by Georgia Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will test new algorithms for robotic exoskeletons by having individuals who have previously had a stroke walk while wearing the device. The goal is to compare the performance of the advanced algorithm with not using the device to determine the clinical benefit.
Who is the study for?
This trial is for individuals aged 18-85 who've had a stroke at least 6 months ago, can walk a bit without support, and have basic mental and physical capabilities to participate in the study. Those with severe neurological conditions other than stroke, recent concussions, certain heart diseases, or major sensory impairments cannot join.Check my eligibility
What is being tested?
The trial tests an advanced robotic hip exoskeleton designed to enhance walking post-stroke. Participants will use this device on a treadmill while researchers compare their gait performance with and without the exoskeleton's new algorithms.See study design
What are the potential side effects?
Potential side effects may include discomfort from wearing the device, skin irritation where it attaches to the body, muscle fatigue due to exercise or unusual movements during testing.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Self-Selected Walking Speed
Trial Design
1Treatment groups
Experimental Treatment
Group I: Powered Hip Exoskeleton for Stroke AssistanceExperimental Treatment1 Intervention
This study will be conducted on a sample population of stroke subjects (single arm). Each subject will test with each condition of the exoskeleton (repeated measures).
Find a Location
Who is running the clinical trial?
Georgia Institute of TechnologyLead Sponsor
49 Previous Clinical Trials
5,534 Total Patients Enrolled
5 Trials studying Stroke
101 Patients Enrolled for Stroke
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,978 Previous Clinical Trials
2,680,341 Total Patients Enrolled
79 Trials studying Stroke
5,375 Patients Enrolled for Stroke
Aaron Young, Ph.D.Principal InvestigatorGeorgia Institute of Technology
3 Previous Clinical Trials
30 Total Patients Enrolled
1 Trials studying Stroke
10 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 85 years old.I need a walker to move around on my own.I walk with a shuffling pattern.I need someone's help to walk.I can walk by myself without anyone's help.I feel I can safely do what the study asks of me.I had a stroke more than 6 months ago.
Research Study Groups:
This trial has the following groups:- Group 1: Powered Hip Exoskeleton for Stroke Assistance
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger